Gene · 7307
Papers3,382
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,021 to 1,040 of 3,382
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| JAK2 V617F polycythemia vera and essential thrombocythemia: dynamic clinical features associated with long-term outcomes. | Blood Cancer J | 2022 | 35395836 | PubTator, text mining | PubMed |
| Low-Risk Myelodysplastic Syndrome Revisited: Morphological, Autoimmune, and Molecular Features as Predictors of Outcome in a Single Center Experience. | Front Oncol | 2022 | 35392224 | PubTator, text mining | PubMed |
| Transcriptome-wide subtyping of pediatric and adult T cell acute lymphoblastic leukemia in an international study of 707 cases. | Proc Natl Acad Sci U S A | 2022 | 35385357 | PubTator, text mining | PubMed |
| Bayesian networks elucidate complex genomic landscapes in cancer. | Commun Biol | 2022 | 35379892 | PubTator, text mining | PubMed |
| Multilayered control of splicing regulatory networks by DAP3 leads to widespread alternative splicing changes in cancer. | Nat Commun | 2022 | 35379802 | PubTator, text mining | PubMed |
| Concordance of Peripheral Blood and Bone Marrow Next-Generation Sequencing in Hematologic Neoplasms. | Adv Hematol | 2022 | 35378848 | PubTator, text mining | PubMed |
| Structural and genome-wide analyses suggest that transposon-derived protein SETMAR alters transcription and splicing. | J Biol Chem | 2022 | 35378129 | PubTator, text mining | PubMed |
| The Coming of Age of Preclinical Models of MDS. | Front Oncol | 2022 | 35372085 | PubTator, text mining | PubMed |
| Unique features of transcription termination and initiation at closely spaced tandem human genes. | Mol Syst Biol | 2022 | 35362230 | PubTator, text mining | PubMed |
| Methylation of SPRED1: A New Target in Acute Myeloid Leukemia. | Front Oncol | 2022 | 35359401 | PubTator, text mining | PubMed |
| Daemonorops draco Blume Induces Apoptosis Against Acute Myeloid Leukemia Cells via Regulation of the miR-216b/c-Jun. | Front Oncol | 2022 | 35356209 | PubTator, text mining | PubMed |
Morphologic, immunophenotypic, and molecular genetic comparison study in patients with clonal cytopenia of undetermined significance, myelodysplastic syndrome, and acute myeloid leukemia with myelodysplasia-related changes: A single institution experience. | Int J Lab Hematol | 2022 | 35352484 | PubTator, text mining | PubMed |
| Actin-related protein 5 functions as a novel modulator of MyoD and MyoG in skeletal muscle and in rhabdomyosarcoma. | Elife | 2022 | 35348112 | PubTator, text mining | PubMed |
| Role of Pharmacogenetics in the Treatment of Acute Myeloid Leukemia: Systematic Review and Future Perspectives. | Pharmaceutics | 2022 | 35335935 | PubTator, text mining | PubMed |
| Thromboinflammation in Myeloproliferative Neoplasms (MPN)-A Puzzle Still to Be Solved. | Int J Mol Sci | 2022 | 35328626 | PubTator, text mining | PubMed |
| TP53 Expression and Mutational Analysis in Hematological Malignancy in Jeddah, Saudi Arabia. | Diagnostics (Basel) | 2022 | 35328276 | PubTator, text mining | PubMed |
| Deep sequencing in CD34+ cells from peripheral blood enables sensitive detection of measurable residual disease in AML. | Blood Adv | 2022 | 35320339 | PubTator, text mining | PubMed |
| DNA repair defects in cancer and therapeutic opportunities. | Genes Dev | 2022 | 35318271 | PubTator, text mining | PubMed |
| Translating recent advances in the pathogenesis of acute myeloid leukemia to the clinic. | Genes Dev | 2022 | 35318270 | PubTator, text mining | PubMed |
| Deoxynivalenol triggers porcine intestinal tight junction disorder through hijacking SLC5A1 and PGC1α-mediated mitochondrial function. | Food Chem Toxicol | 2022 | 35307453 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7307/papers?page=52